key: cord-0907714-s1mym0kq authors: Kosugi, Eduardo Macoto; Lavinsky, Joel; Romano, Fabrizio Ricci; Fornazieri, Marco Aurélio; Luz-Matsumoto, Gabriela Ricci; Lessa, Marcus Miranda; Piltcher, Otavio; Sant’Anna, Geraldo Druck title: Incomplete and late recovery of sudden olfactory dysfunction in COVID-19() date: 2020-05-25 journal: Braz J Otorhinolaryngol DOI: 10.1016/j.bjorl.2020.05.001 sha: 078ae63961e3c3f403a6a4d30c6a918fedab5f16 doc_id: 907714 cord_uid: s1mym0kq INTRODUCTION: Sudden olfactory dysfunction is a new symptom related to COVID-19, with little data on its duration or recovery rate. OBJECTIVE: To characterize patients with sudden olfactory disfunction during the COVID-19 pandemic, especially their recovery data. METHODS: An online survey was conducted by the Brazilian Society of Otorhinolaryngology and Cervico-Facial Surgery, and Brazilian Academy of Rhinology, including doctors who assessed sudden olfactory dysfunction patients starting after February 1(st), 2020. RESULTS: 253 sudden olfactory dysfunction patients were included, of which 59.1% were females with median age of 36 years, with a median follow-up period of 31 days. 183 patients (72.3%) had been tested for COVID-19, and of those 145 (79.2%) tested positive. Patients that tested positive for COVID-19 more frequently showed non-specific inflammatory symptoms (89.7% vs. 73.7%; p = 0.02), a lower rate of total recovery of sudden olfactory dysfunction (52.6% vs. 70.3%; p = 0.05) and a longer duration to achieve total recovery (15 days vs. 10 days; p = 0.0006) than the ones who tested negative for COVID-19. Considering only positive-COVID-19 patients, individuals with sudden hyposmia completely recovered more often than the ones with sudden anosmia (68.4% vs. 50.0%; p = 0.04). CONCLUSION: Positive-COVID-19 patients with sudden olfactory dysfunction showed lower total recovery rate and longer duration than negative-COVID-19 patients. Additionally, total recovery was seen more frequently in positive-COVID-19 patients with sudden hyposmia than the ones with sudden anosmia. 7> < colspeccolname =col1/ >< colspeccolname =col2/ >< colspeccolname =col3/ >< colspeccolname =col4/ >< colspeccolname =col5/ >< colspeccolname =col6/ >< colspeccolname =col7/ >< theadvalign =ẗop> < row >< entrynamest =col1nameend = col2rowsep =1älign =left>Characteristicsoftestedpatients(n < ce : hspsp =0.25/ > = < ce : hspsp =0.25/ > 183) < /entry >< entrynamest =col3nameend =col6rowsep =1älign = left>COVID − 19test < /entry >< entry/ >< /row >< row >< entryrowsep =1/ >< entryrowsep =1/ >< entrynamest =col3nameend =col4rowsep =1älign =left>Positive(n < ce : hspsp =0.25/ > = < ce : hspsp =0.25/ > 145) < /entry >< entrynamest = col5nameend =col6rowsep =1älign =left>Negative(n < ce : hspsp =0.25/ > = < ce : hspsp =0.25/ > 38) < /entry >< entryrowsep =1älign =left>p−value < /entry >< /row >< /thead >< tbody >< row >< entryalign =leftrole =rowhead>Age(years) < /entry >< entryalign =left>MedandIQR < /entry >< entryalign =left>36 < /entry >< entryalign =left>31-44 < /entry >< entryalign =left>35.5 < /entry >< entryalign = left>30.25-45.25 < /entry >< entryalign =left>0.60 < /entry >< /row >< row >< entryalign =leftrole =rowhead>Follow − up(days) < /entry >< entryalign = left>MedandIQR < /entry >< entryalign =left>31 < /entry >< entryalign =left>12-39 < /entry >< entryalign =left>35.5 < /entry >< entryalign =left>17-41 < /entry >< entryalign =left>0.37 < /entry >< /row >< row >< entryalign =leftrole = rowhead>Femalegender < /entry >< entryalign =left>ne% < /entry >< entryalign = left>77 < /entry >< entryalign =left>53.1 < /entry >< entryalign =left>26 < /entry >< entryalign =left>68.4 < /entry >< entryalign =left>0.10 < /entry >< /row >< row >< entryalign =leftrole =rowhead>AcuteAnosmia < /entry >< entryalign =left>ne% < /entry >< entryalign =left>126 < /entry >< entryalign =left>86.9 < /entry >< entryalign =left>31 < /entry >< entryalign =left>81.6 < /entry >< entryalign = left>0.44 < /entry >< /row >< row >< entryalign =leftrole =rowhead>AcuteHyposmia < /entry >< entryalign =left>ne% < /entry >< entryalign =left>19 < /entry >< entryalign = left>13.1 < /entry >< entryalign =left>7 < /entry >< entryalign =left>18.4 < /entry >< entryalign =left>0.44 < /entry >< /row >< row >< entryalign =leftrole = rowhead>Comorbidities < /entry >< entryalign =left>ne% < /entry >< entryalign = left>47 < /entry >< entryalign =left>32.4 < /entry >< entryalign =left>15 < /entry >< entryalign =left>39.5 < /entry >< entryalign =left>0.44 < /entry >< /row >< row >< entryalign =leftrole =rowhead>AllergicRhinitis < /entry >< entryalign =left>ne% < /entry >< entryalign =left>22 < /entry >< entryalign =left>15.2 < /entry >< entryalign = left>8 < /entry >< entryalign =left>21.1 < /entry >< entryalign =left>0.46 < /entry >< /row >< row >< entryalign =leftrole =rowhead>Asthma < /entry >< entryalign = left>ne% < /entry >< entryalign =left>7 < /entry >< entryalign =left>4.8 < /entry >< entryalign =left>0 < /entry >< entryalign =left>0.0 < /entry >< entryalign =left>0.35 < /entry >< /row >< /tbody >< /tgroup >< ce : legend >< ce : simple − paraid = spar0065>n, Number; Med, Median; IQR, InterquartileRange; %, Percentage. < /ce : simple − para >< /ce : legend >< /ce : table >< ce : tableid =ẗbl0010f rame = topbotrowsep =0colsep =0> < ce : label > Table2 < /ce : label >< ce : captionid = cap0015> < ce : simple − paraid =spar0070>SymptomsofpatientstestedforCOVID − 19. < /ce : simple − para >< /ce : caption >< ce : alt − textid =ät2role =short>Table2 < /ce : alt − text >< tgroupcols =6> < colspeccolname =col1/ >< colspeccolname =col2/ >< colspeccolname =col3/ >< colspeccolname =col4/ >< colspeccolname =col5/ >< colspeccolname =col6/ >< theadvalign =ẗop> < row >< entryalign =leftrole = rowhead>Symptomsoftestedpatients < ce : br/ > (n < ce : hspsp =0.25/ > = < ce : hspsp = 0.25/ > 183) < /entry >< entrynamest =col2nameend =col5rowsep =1älign = left>COVID − 19Test < /entry >< entryalign =left>p−value < /entry >< /row >< row >< entryrowsep =1/ >< entrynamest =col2nameend =col3rowsep =1älign =left>Positive < ce : br/ > (n < ce : hspsp =0.25/ > = < ce : hspsp =0.25/ > 145) < /entry >< entrynamest =col4nameend =col5rowsep =1älign =left>Negative < ce : br/ > (n < ce : hspsp =0.25/ > = < ce : hspsp =0.25/ > 38) < /entry >< entryrowsep =1/ >< /row >< /thead >< tbody >< row >< entry/ >< entryalign =left>n < /entry >< entryalign = left>% < /entry >< entryalign =left>n < /entry >< entryalign =left>% < /entry >< entry/ >< /row >< row >< entryalign =leftrole =rowhead>None < /entry >< entryalign = left>8 < /entry >< entryalign =left>5.5 < /entry >< entryalign =left>5 < /entry >< entryalign =left>13.1 < /entry >< entryalign =left>0.15 < /entry >< /row >< row >< entryalign =leftrole =rowhead>Nonspecificsymptoms < /entry >< entryalign =left>130 < /entry >< entryalign =left>89.7 < /entry >< entryalign =left>28 < /entry >< entryalign = left>73.7 < /entry >< entryalign =left>0.02 < ce : cross − refid =crf 0005refid = tblfn0005> a Coughing8357.21847.30.36Headache7652.42052.61.00Fever7249.71642.10.47Myalgia/arthralgia3725.5821.00.68Fatigue2013.7718.40.14Anorexia42.725.20.61Nasal Symptoms6242.71539.40.85Nasal Obstruction4027.5821.00.54Sneezing1812.4410.51.00Coryza3121.3821.01.00Rhinorrhea21.312.60.51Nasal Pruritus64.125.20.67URTIs (nose and/or throat)6645.51642.10.86Sore throat106.9410.50.56OthersDyspnea74.825.21.00Diarrhea106.912.60.46Ageusia64.125.20.67n, Number; %, Percentage.aStatistical Significance.Table 3Recovery from loss of olfaction in patients tested for COVID-19.Table 3Recovery from sudden olfactory dysfunction (n=174)COVID-19 Testp-valuePositive (n=137)Negative (n=37)Full recoveryn and %7252.62670.30.05 a Partial recoveryn and %4633.61027.0No recoveryn and %1913.912.7Time to full recoveryMed and IQR1510-21108-12.750.0006 a n, Number; %, Percentage; Med, Median; IQR, Interquartile Range.aStatistical significance.Table 4Recovery from acute anosmia and hyposmia in positive-COVID-19 patients.Table 4Recovery from sudden olfactory dysfunction (n=137)Positive-COVID-19p-valueAnosmia (n=118)Hyposmia (n=19)Full recoveryn and %5950.01368.4Partial recoveryn and %4437.3210.50.04 a No recoveryn and %1512.7421.1Time to full recoveryMed and IQR15.510.75-23119-160.10n, Number; %, Percentage; Med, Median; IQR, Interquartile Range.aStatistical significance.Please cite this article as: Kosugi EM, Lavinsky J, Romano FR, Fornazieri MA, Luz-Matsumoto GR, Lessa MM, et al. Recuperação incompleta e tardia da perda súbita do olfato na COVID-19. https://doi.org/10.1016/j.bjorl.2020.05.001Peer Review under the responsibility of Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial.Original ArticleIncomplete and late recovery of sudden olfactory dysfunction in COVID-19Please check the short title that has been created, or suggest an alternative of fewer than 80 characters including spaces.->Incomplete and late recovery of sudden olfactory dysfunction in COVID-19->Recuperação incompleta e tardia da perda súbita do olfato na COVID-19Eduardo MacotoKosugiPlease confirm that given name and surname are correctly identified. The different colors indicate whether tagged as first or last name. Please note that proper identification is key for correct indexing of the article.-> a b x204E edumacoto@gmail.comJoelLavinsky b Fabrizio RicciRomano a b Marco AurélioFornazieri a Gabriela RicciLuz-Matsumoto a Marcus MirandaLessa a OtavioPiltcher a Geraldo DruckSant'Anna b aAcademia Brasileira de Rinologia (ABR), ->São Paulo->, ->SP->, ->Brazil->Academia Brasileira de Rinologia (ABR)São PauloSPBrazilbAssociação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial (ABORL-CCF), ->São Paulo->, ->SP->, ->Brazil->Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial (ABORL-CCF)São PauloSPBrazil*Corresponding author.AbstractIntroductionSudden olfactory dysfunction is a new symptom related to COVID-19, with little data on its duration or recovery rate.ObjectiveTo characterize patients with sudden olfactory disfunction during the COVID-19 pandemic, especially their recovery data.MethodsAn online survey was conducted by the Brazilian Society of Otorhinolaryngology and Cervico-Facial Surgery, and Brazilian Academy of Rhinology, including doctors who assessed sudden olfactory dysfunction patients starting after February 1 st , 2020.Results253 sudden olfactory dysfunction patients were included, of which 59.1% were females with median age of 36 years, with a median follow-up period of 31 days. 183 patients (72.3%) had been tested for COVID-19, and of those 145 (79.2%) tested positive. Patients that tested positive for COVID-19 more frequently showed non-specific inflammatory symptoms (89.7% vs. 73.7%; p=0.02), a lower rate of total recovery of sudden olfactory dysfunction (52.6% vs. 70.3%; p=0.05) and a longer duration to achieve total recovery (15 days vs. 10 days; p=0.0006) than the ones who tested negative for COVID-19. Considering only positive-COVID-19 patients, individuals with sudden hyposmia completely recovered more often than the ones with sudden anosmia (68.4% vs. 50.0%; p=0.04).ConclusionPositive-COVID-19 patients with sudden olfactory dysfunction showed lower total recovery rate and longer duration than negative-COVID-19 patients. Additionally, total recovery was seen more frequently in positive-COVID-19 patients with sudden hyposmia than the ones with sudden anosmia.ResumoIntroduccedil;atilde;oA perda suacute;bita do olfato eacute; um novo sintoma relacionado agrave; COVID-19, poreacute;m com poucos dados sobre sua duraccedil;atilde;o ou resoluccedil;atilde;o.ObjetivoCaracterizar pacientes que apresentaram perda suacute;bita do olfato durante a pandemia da COVID-19, e em especial a sua recuperaccedil;atilde;o.Meacute;todoPesquisa online desenvolvida pela Associaccedil;atilde;o Brasileira de Otorrinolaringologia e Cirurgia Ceacute;rvico-Facial e Academia Brasileira de Rinologia direcionado aos meacute;dicos que atenderam pacientes com perda suacute;bita do olfato com iniacute;cio apoacute;s 01 de fevereiro de 2020.ResultadosForam incluiacute;dos 253 pacientes com perda suacute;bita de olfato, sendo 59,1% mulheres e idade mediana de 36 anos, acompanhados por 31 dias (mediana >0,04) .Conclusatilde;oA perda suacute;bita do olfato em pacientes COVID-19 positivos apresentou menor taxa de recuperaccedil;atilde;o total e duraccedil;atilde;o mais prolongada do que em COVID-19 negativos. E a hiposmia suacute;bita apresentou recuperaccedil;atilde;o total mais frequentemente que a anosmia suacute;bita em COVID-19 positivos.KeywordsCOVID-19AnosmiaOlfactory disordersPalavras-chaveCOVID-19AnosmiaTranstornos do olfatoIntroduction